美国 · SEC FORM 4
MeiraGTx Holdings plc
MGTX · Nasdaq · CIK 0001735438 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
9 同一窗口内观察到的 Form 4 交易行
7 sales · 2 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-08-12 · EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 5,996,760
- 上期报告
- 4,011,818
- 日均成交量
- 1,190,432
- 回补天数
- 5.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-08-12 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Ordinary Shares | 1,250,000 | USD 4.00 | USD 5,000,000 | SEC 申报 ↗ |
| 2023-05-05 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Ordinary Shares | 4,347,826 | USD 5.75 | USD 25,000,000 | SEC 申报 ↗ |
| 2022-06-03 | Zeldin Robert K | 买入 (P) | Ordinary Shares | 5,000 | USD 7.90 | USD 39,500 | SEC 申报 ↗ |
| 2022-05-25 | Wollin Robert J | 买入 (P) | Ordinary Shares | 1,000 | USD 7.94 | USD 7,940 | SEC 申报 ↗ |
| 2020-11-23 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Ordinary Shares | 500,000 | USD 12.85 | USD 6,425,000 | SEC 申报 ↗ |
Form 4 申报证据
46 transaction lines in the latest 365-day window; 236 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Naylor Stuart | 卖出 (S) | Ordinary Shares | 27,659 | USD 10.64 | USD 294,292 | SEC 申报 ↗ |
| 2026-08-18 | Forbes Alexandria | 卖出 (S) | Ordinary Shares | 62,000 | USD 13.86 | USD 859,320 | SEC 申报 ↗ |
| 2026-07-21 | Giroux Richard | 卖出 (S) | Ordinary Shares | 56,000 | USD 12.51 | USD 700,560 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Naylor Stuart | 卖出 (S) | Ordinary Shares | 27,659 | USD 10.64 | USD 294,292 | SEC 申报 ↗ |
| 2026-08-18 | Forbes Alexandria | 卖出 (S) | Ordinary Shares | 62,000 | USD 13.86 | USD 859,320 | SEC 申报 ↗ |
| 2026-07-21 | Giroux Richard | 卖出 (S) | Ordinary Shares | 56,000 | USD 12.51 | USD 700,560 | SEC 申报 ↗ |
| 2026-07-07 | Naylor Stuart | 卖出 (S) | Ordinary Shares | 27,659 | USD 14.80 | USD 409,470 | SEC 申报 ↗ |
| 2026-06-10 | Harris Keith R. | 期权行权/转换 (M) | Ordinary Shares | 75,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-27 | Giroux Richard | 赠与 (G) | Ordinary Shares | 7,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | Forbes Alexandria | 卖出 (S) | Ordinary Shares | 62,000 | USD 9.17 | USD 568,540 | SEC 申报 ↗ |
| 2026-04-21 | Giroux Richard | 卖出 (S) | Ordinary Shares | 56,000 | USD 10.22 | USD 572,320 | SEC 申报 ↗ |
| 2026-04-17 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 奖励/授予 (A) | Ordinary Shares | 555,555 | USD 9.00 | USD 4,999,995 | SEC 申报 ↗ |
| 2026-04-07 | Naylor Stuart | 卖出 (S) | Ordinary Shares | 27,661 | USD 9.36 | USD 258,907 | SEC 申报 ↗ |
| 2026-03-24 | Forbes Alexandria | 卖出 (S) | Ordinary Shares | 62,000 | USD 7.41 | USD 459,420 | SEC 申报 ↗ |
| 2026-02-21 | Zeldin Robert K | 期权行权/转换 (M) | Ordinary Shares | 7,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-21 | Zeldin Robert K | 代扣税 (F) | Ordinary Shares | 2,952 | USD 7.45 | USD 21,992 | SEC 申报 ↗ |
| 2026-02-21 | Wollin Robert J | 期权行权/转换 (M) | Ordinary Shares | 11,250 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-21 | Wollin Robert J | 代扣税 (F) | Ordinary Shares | 5,949 | USD 7.45 | USD 44,320 | SEC 申报 ↗ |
| 2026-02-21 | Naylor Stuart | 期权行权/转换 (M) | Ordinary Shares | 25,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-21 | Naylor Stuart | 代扣税 (F) | Ordinary Shares | 11,750 | USD 7.45 | USD 87,538 | SEC 申报 ↗ |
| 2026-02-21 | Giroux Richard | 期权行权/转换 (M) | Ordinary Shares | 60,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-21 | Giroux Richard | 代扣税 (F) | Ordinary Shares | 31,726 | USD 7.45 | USD 236,359 | SEC 申报 ↗ |
| 2026-02-21 | Forbes Alexandria | 期权行权/转换 (M) | Ordinary Shares | 62,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-21 | Forbes Alexandria | 代扣税 (F) | Ordinary Shares | 33,048 | USD 7.45 | USD 246,208 | SEC 申报 ↗ |
| 2026-01-17 | Zeldin Robert K | 期权行权/转换 (M) | Ordinary Shares | 35,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-17 | Zeldin Robert K | 代扣税 (F) | Ordinary Shares | 13,951 | USD 7.42 | USD 103,516 | SEC 申报 ↗ |
| 2026-01-17 | Wollin Robert J | 期权行权/转换 (M) | Ordinary Shares | 50,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-17 | Wollin Robert J | 代扣税 (F) | Ordinary Shares | 27,206 | USD 7.42 | USD 201,869 | SEC 申报 ↗ |
| 2026-01-17 | Naylor Stuart | 期权行权/转换 (M) | Ordinary Shares | 75,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-17 | Naylor Stuart | 代扣税 (F) | Ordinary Shares | 35,250 | USD 7.42 | USD 261,555 | SEC 申报 ↗ |
| 2026-01-17 | Giroux Richard | 期权行权/转换 (M) | Ordinary Shares | 310,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-17 | Giroux Richard | 代扣税 (F) | Ordinary Shares | 163,916 | USD 7.42 | USD 1,216,257 | SEC 申报 ↗ |
| 2026-01-17 | Forbes Alexandria | 期权行权/转换 (M) | Ordinary Shares | 310,000 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | MGTX |
| CIK | 0001735438 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 236 transaction lines from 2020-01-21 to 2026-10-06 6 P purchase lines · 86 S sale lines · 144 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.